<code id='E4415A8915'></code><style id='E4415A8915'></style>
      • <acronym id='E4415A8915'></acronym>
      <center id='E4415A8915'><center id='E4415A8915'><tfoot id='E4415A8915'></tfoot></center><abbr id='E4415A8915'><dir id='E4415A8915'><tfoot id='E4415A8915'></tfoot><noframes id='E4415A8915'>
      • <optgroup id='E4415A8915'><strike id='E4415A8915'><sup id='E4415A8915'></sup></strike><code id='E4415A8915'></code></optgroup>
        5. <b id='E4415A8915'><label id='E4415A8915'><select id='E4415A8915'><dt id='E4415A8915'><span id='E4415A8915'></span></dt></select></label></b><u id='E4415A8915'></u>
          <i id='E4415A8915'><strike id='E4415A8915'><tt id='E4415A8915'><pre id='E4415A8915'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-10-04 11:08:00 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：94
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          NASA releases new images of 'fingerprint
                                
                            
          Next article：  
                                      
                                          Heart attack and stroke risk calculators need revising
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles